US FDA issues import alert for Wockhardt’s Chikalthana facility at Aurangabad

27 Nov 2013 Evaluate

US Food and Drug Administration (US FDA) has imposed an import alert for the drug maker Wockhardt’s Chikalthana facility at Aurangabad. An import alert results in the detention without physical examination of drugs from firms that have not met so-called good manufacturing practices.

Meanwhile, the company dropped from the Morgan Stanley Capital International (MSCI) India index with effect from November 26, 2013. MSCI is a leading provider of benchmark indices globally.

Wockhardt is one of the few companies with end to end integrated capabilities for its products, starting with the manufacture of the oral and sterile API’s, the dose forms and marketing through wholly owned subsidiary in the US, enabling the company to capture maximum value.

Wockhardt Share Price

1360.10 28.75 (2.16%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×